» Articles » PMID: 24519863

Allopurinol Enhances the Blood Pressure Lowering Effect of Enalapril in Children with Hyperuricemic Essential Hypertension

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2014 Feb 13
PMID 24519863
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Essential hypertension is frequently associated with hyperuricemia in both adult and pediatric patients. Lowering serum uric acid level may provide greater benefit than simply treating hypertension.

Patients And Methods: Forty-four adolescents, aged 12-19 years, newly diagnosed as essential hypertension (secondary hypertension was excluded) and previously untreated were randomized (open label trial) to receive either enalapril or enalapril plus allopurinol in combination. All participants had baseline serum uric acid level ≥5.5 mg/dl.

Results: Baseline mean blood pressure (BP), age and body mass index were similar between the two groups. After 8 weeks' treatment, BP reduction was greater, percent of treatment group achieving target BP level was greater, and serum uric acid level was lower in the combination treatment group. There were no adverse effects during the course of therapy.

Conclusion: Results suggest that uric acid reduction may be used as adjunctive antihypertensive therapy in hypertensive adolescents with hyperuricemia while closely monitoring for any adverse effect.

Citing Articles

Efficacy and Safety of Allopurinol on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis.

Sharbaf F, Bakhtiari E, Faghihi T, Assadi F J Pediatr Pharmacol Ther. 2024; 29(4):359-367.

PMID: 39144382 PMC: 11321800. DOI: 10.5863/1551-6776-29.4.359.


The Role of Uric Acid in Human Health: Insights from the Gene.

Roman Y J Pers Med. 2023; 13(9).

PMID: 37763176 PMC: 10532990. DOI: 10.3390/jpm13091409.


Serum Uric Acid Might Be Positively Associated With Hypertension in Chinese Adults: An Analysis of the China Health and Nutrition Survey.

Han Y, Han K, Han X, Yin Y, Di H, Wu J Front Med (Lausanne). 2022; 8:755509.

PMID: 35071258 PMC: 8766717. DOI: 10.3389/fmed.2021.755509.


FGF21 attenuates high uric acid‑induced endoplasmic reticulum stress, inflammation and vascular endothelial cell dysfunction by activating Sirt1.

Ouyang R, Zhao X, Zhang R, Yang J, Li S, Deng D Mol Med Rep. 2021; 25(1).

PMID: 34850960 PMC: 8669652. DOI: 10.3892/mmr.2021.12551.


Uric Acid and Hypertension: Prognostic Role and Guide for Treatment.

Piani F, Cicero A, Borghi C J Clin Med. 2021; 10(3).

PMID: 33498870 PMC: 7865830. DOI: 10.3390/jcm10030448.


References
1.
Perlstein T, Gumieniak O, Hopkins P, Murphey L, Brown N, Williams G . Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004; 66(4):1465-70. DOI: 10.1111/j.1523-1755.2004.00909.x. View

2.
Grayson P, Kim S, LaValley M, Choi H . Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 63(1):102-10. PMC: 3016454. DOI: 10.1002/acr.20344. View

3.
Farquharson C, Butler R, Hill A, Belch J, Struthers A . Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002; 106(2):221-6. DOI: 10.1161/01.cir.0000022140.61460.1d. View

4.
Mazzali M, Hughes J, Kim Y, Jefferson J, Kang D, Gordon K . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38(5):1101-6. DOI: 10.1161/hy1101.092839. View

5.
Krishnan E, Kwoh C, Schumacher H, Kuller L . Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2006; 49(2):298-303. DOI: 10.1161/01.HYP.0000254480.64564.b6. View